|
JP2010500300A
(ja)
|
2006-08-08 |
2010-01-07 |
サノフィ−アベンティス |
アリールアミノアリール−アルキル−置換イミダゾリジン−２，４−ジオン、それらの製造法、それらの化合物を含有する薬剤、およびそれらの使用
|
|
EP2002835A1
(en)
|
2007-06-04 |
2008-12-17 |
GenKyo Tex |
Pyrazolo pyridine derivatives as NADPH oxidase inhibitors
|
|
EP2000176A1
(en)
|
2007-06-04 |
2008-12-10 |
GenKyo Tex |
Tetrahydroindole derivatives as NADPH Oxidase inhibitors
|
|
EP2025674A1
(de)
|
2007-08-15 |
2009-02-18 |
sanofi-aventis |
Substituierte Tetrahydronaphthaline, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
|
|
CA2704266A1
(en)
|
2007-11-02 |
2009-06-11 |
Vertex Pharmaceuticals Incorporated |
[1h- pyrazolo [3, 4-b] pyridine-4-yl] -phenyle or -pyridin-2-yle derivatives as protein kinase c-theta
|
|
WO2010003624A2
(en)
|
2008-07-09 |
2010-01-14 |
Sanofi-Aventis |
Heterocyclic compounds, processes for their preparation, medicaments comprising these compounds, and the use thereof
|
|
EP2166010A1
(en)
|
2008-09-23 |
2010-03-24 |
Genkyo Tex Sa |
Pyrazolo pyridine derivatives as NADPH oxidase inhibitors
|
|
EP2166009A1
(en)
*
|
2008-09-23 |
2010-03-24 |
Genkyo Tex Sa |
Pyrazolo pyridine derivatives as nadph oxidase inhibitors
|
|
EP2165707A1
(en)
|
2008-09-23 |
2010-03-24 |
Genkyo Tex Sa |
Pyrazolo pyridine derivatives as NADPH oxidase inhibitors
|
|
EP2166008A1
(en)
|
2008-09-23 |
2010-03-24 |
Genkyo Tex Sa |
Pyrazolo pyridine derivatives as NADPH oxidase inhibitors
|
|
WO2010044441A1
(ja)
|
2008-10-17 |
2010-04-22 |
塩野義製薬株式会社 |
血管内皮リパーゼ阻害活性を有する酢酸アミド誘導体
|
|
WO2010068601A1
(en)
|
2008-12-08 |
2010-06-17 |
Sanofi-Aventis |
A crystalline heteroaromatic fluoroglycoside hydrate, processes for making, methods of use and pharmaceutical compositions thereof
|
|
MX2012001729A
(es)
|
2009-08-26 |
2012-06-13 |
Sanofi Sa |
Nuevos hidratos cristalinos de fluoroglicosido heteroaromatico, productos farmaceuticos que comprenden estos compuestos, y su empleo.
|
|
EP2305679A1
(en)
|
2009-09-28 |
2011-04-06 |
GenKyoTex SA |
Pyrazoline dione derivatives as nadph oxidase inhibitors
|
|
CN102753545A
(zh)
|
2009-12-15 |
2012-10-24 |
盐野义制药株式会社 |
具有血管内皮脂酶抑制活性的噁二唑衍生物
|
|
WO2011107494A1
(de)
|
2010-03-03 |
2011-09-09 |
Sanofi |
Neue aromatische glykosidderivate, diese verbindungen enthaltende arzneimittel und deren verwendung
|
|
WO2011157827A1
(de)
|
2010-06-18 |
2011-12-22 |
Sanofi |
Azolopyridin-3-on-derivate als inhibitoren von lipasen und phospholipasen
|
|
US8530413B2
(en)
|
2010-06-21 |
2013-09-10 |
Sanofi |
Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments
|
|
TW201215388A
(en)
|
2010-07-05 |
2012-04-16 |
Sanofi Sa |
(2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments
|
|
TW201221505A
(en)
|
2010-07-05 |
2012-06-01 |
Sanofi Sa |
Aryloxyalkylene-substituted hydroxyphenylhexynoic acids, process for preparation thereof and use thereof as a medicament
|
|
TW201215387A
(en)
|
2010-07-05 |
2012-04-16 |
Sanofi Aventis |
Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament
|
|
GB2497476B
(en)
*
|
2010-09-06 |
2018-01-10 |
Guangzhou Inst Biomed & Health |
Amide Compounds
|
|
WO2012120052A1
(de)
|
2011-03-08 |
2012-09-13 |
Sanofi |
Mit carbozyklen oder heterozyklen substituierte oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung
|
|
EP2683705B1
(de)
|
2011-03-08 |
2015-04-22 |
Sanofi |
Di- und trisubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
|
|
EP2683699B1
(de)
|
2011-03-08 |
2015-06-24 |
Sanofi |
Di- und trisubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
|
|
US8828995B2
(en)
|
2011-03-08 |
2014-09-09 |
Sanofi |
Branched oxathiazine derivatives, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof
|
|
US8871758B2
(en)
|
2011-03-08 |
2014-10-28 |
Sanofi |
Tetrasubstituted oxathiazine derivatives, method for producing them, their use as medicine and drug containing said derivatives and the use thereof
|
|
WO2013037390A1
(en)
|
2011-09-12 |
2013-03-21 |
Sanofi |
6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
|
|
EP2760862B1
(en)
|
2011-09-27 |
2015-10-21 |
Sanofi |
6-(4-hydroxy-phenyl)-3-alkyl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
|
|
WO2013048982A1
(en)
|
2011-09-27 |
2013-04-04 |
Bristol-Myers Squibb Company |
Pyrrolinone carboxamide compounds useful as endothelial lipase inhibitors
|
|
EP2760828B1
(en)
|
2011-09-27 |
2015-10-21 |
Bristol-Myers Squibb Company |
Pyrrolinone carboxamide compounds useful as endothelial lipase inhibitors
|
|
EP2760830B1
(en)
|
2011-09-27 |
2016-08-03 |
Bristol-Myers Squibb Company |
Pyrrolinone carboxamide compounds useful as endothelial lipase inhibitors
|
|
EP2760839B1
(en)
|
2011-09-30 |
2015-11-25 |
Bristol-Myers Squibb Company |
Pyridinedione carboxamide inhibitors of endothelial lipase
|
|
US8946430B2
(en)
|
2011-09-30 |
2015-02-03 |
Bristol-Myers Squibb Company |
Quinolinone carboxamide inhibitors of endothelial lipase
|
|
US8933235B2
(en)
|
2011-09-30 |
2015-01-13 |
Bristol-Myers Squibb Company |
Pyridinedione carboxamide inhibitors of endothelial lipase
|
|
US9199946B2
(en)
|
2012-04-03 |
2015-12-01 |
Bristol-Myers Squibb Company |
Pyrimidinone carboxamide inhibitors of endothelial lipase
|
|
US9394260B2
(en)
|
2012-04-03 |
2016-07-19 |
Bristol-Myers Squibb Company |
Pyrimidinone carboxamide inhibitors of endothelial lipase
|
|
WO2014011513A1
(en)
|
2012-07-09 |
2014-01-16 |
Bristol-Myers Squibb Company |
Sulfonyl containing benzothiazole inhibitors of endothelial lipase
|
|
US9139578B2
(en)
|
2012-07-09 |
2015-09-22 |
Bristol-Myers Squibb Company |
Amide or urea containing benzothiazole inhibitors of endothelial lipase
|
|
WO2014015088A1
(en)
|
2012-07-19 |
2014-01-23 |
Bristol-Myers Squibb Company |
Amide, urea or sulfone amide linked benzothiazole inhibitors of endothelial lipase
|
|
WO2014042939A1
(en)
|
2012-09-11 |
2014-03-20 |
Bristol-Myers Squibb Company |
Ketone linked benzothiazole inhibitors of endothelial lipase
|
|
US10173991B2
(en)
|
2014-01-07 |
2019-01-08 |
Bristol-Myers Squibb Company |
Sulfone amide linked benzothiazole inhibitors of endothelial lipase
|
|
EP3288939A1
(en)
|
2015-04-17 |
2018-03-07 |
AbbVie Inc. |
Tricyclic modulators of tnf signaling
|
|
WO2016168633A1
(en)
|
2015-04-17 |
2016-10-20 |
Abbvie Inc. |
Indazolones as modulators of tnf signaling
|
|
US9879016B2
(en)
|
2015-04-17 |
2018-01-30 |
Abbvie Inc. |
Indazolones as modulators of TNF signaling
|
|
WO2017214005A1
(en)
|
2016-06-06 |
2017-12-14 |
Bristol-Myers Squibb Company |
2-(benzothiazol-2-yl)-2-cyano-acetamide derivatives and their use as endothelial lipase inhibitors
|
|
EP3479843A1
(en)
|
2017-11-01 |
2019-05-08 |
GenKyoTex Suisse SA |
Use of nox inhibitors for treatment of cancer
|
|
CN110526898A
(zh)
*
|
2018-05-25 |
2019-12-03 |
北京诺诚健华医药科技有限公司 |
3-吲唑啉酮类化合物、其制备方法及其在医药学上的应用
|
|
KR102919209B1
(ko)
|
2018-08-10 |
2026-01-28 |
다이아핀 테라퓨틱스, 엘엘씨 |
트리-펩타이드 그리고 대사, 심장혈관 및 염증성 장애의 치료
|